MARIAME DIABATE: Open Payments
NPI 1164021671 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 14 payments from 7 companies in 2025. Trend: 2023 $551 · 2024 $436 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $92 |
| Organon LLC | 2 | $53 |
| Sage Therapeutics, LLC | 3 | $47 |
| CooperSurgical, Inc. | 2 | $44 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $19 |
| MILLICENT US INC | 1 | $18 |
Products named: Veozah, ZURZUVAE, Paragard T 380A, GEMTESA, FEMLYV.
Industry payments across VA — which companies pay providers there.
